Vanta Bioscience Ltd.BSE: VANTABIO

Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026

· Issued by Vanta Bioscience Ltd. via BSE India

Filed with BSE · · 1 page · English

On 6ix: 6ix.com/news/board-meeting-intimation-for-approval-of-standalone-and-consolidated-audited-financial-results-for-the-half-year-and-financial-year-ended-march-31-2026-board-meeting-to-be-held-on-may-30-2026

Release

Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31, 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon

Vanta Bioscience Ltd. on 6ix

Story so far

Earlier from Vanta Bioscience

Later from Vanta Bioscience

All Vanta Bioscience news releases